New Review of Critical Decisions
A review of Critical Decisions was recently published in The American Journal of Bioethics. You can check it out here.
(Click here to view comments)
A review of Critical Decisions was recently published in The American Journal of Bioethics. You can check it out here.
(Click here to view comments)
At long last, my new book Critical Decisions is out there, ready to reach (fingers crossed!) a wide and appreciative audience. I’m really excited about this book. It pulls together ideas that have been smoldering in my brain for two decades — research, reflections and experiences (AKA “stories”). In the book, I relate the fascinating…
I recently had the pleasure of discussing my book with Tavis Smiley on his wonderful PBS television show. As you will see, we had some fun back and forth, while still covering some pretty fundamental ground about how to help patients participate more actively in their medical decisions.
Listen to this interview I conducted with a radio station in Australia. Good Q&A about Critical Decisions. Toughest part of the interview was remembering that although it was 4:30 in the afternoon my time, it was 6:30 the next morning for the Aussies!
JoAnn Pushkin’s breast cancer was diagnosed at an advanced stage because the density of her breasts obscured the tumor on her mammograms. That was shocking news to Pushkin, who only learned that her breasts were radiologically dense at the time of her diagnosis. Activated by this revelation, she has become a leading advocate of legislation,…
I’m not sure why I didn’t notice this earlier, but I just came across a very gracious, even overly generous, review of my book, Critical Decisions in the leading journal of bioethics, The Hastings Center Report. I thought I would share it with you: When I finally got eyeglasses as a teenager, after denying the…
Since the recession hit hard a few years ago, health care expenditures have slowed dramatically. It now looks like, at least for medications, cost increases are making a comeback. For instance: Nexium, a heartburn drug, had a 7.8% price hike to a $262 average prescription in the first nine months of 2012. Enough to make…